Abstract
Tyrosine hydroxylase (TH), the rate-limiting enzyme in catecholamine biosynthesis, is inhibited in vitro by catecholamines binding to two distinct sites on the enzyme. The N-terminal regulatory domain of TH contributes to dopamine binding to the high affinity site of the enzyme. We prepared an N-terminal deletion mutant of TH to examine the role of the N-terminal domain in dopamine binding to the low affinity site. Deletion of the N-terminus of TH removes the high affinity dopamine binding site, but does not affect dopamine binding to the low affinity site. The role of the low affinity site in situ was examined by incubating PC12 cells with L-DOPA to increase the cytosolic catecholamine concentration. This resulted in an inhibition of TH activity in situ under both basal conditions and conditions that promoted the phosphorylation of Ser40. Therefore the low affinity site is active in situ regardless of the phosphorylation status of Ser40.
Similar content being viewed by others
References
Nagatsu T, Levitt M, Udenfriend S (1964) Tyrosine hydroxylase. The initial step in norepinephrine biosynthesis. J Biol Chem 239:2910–2917
Kumer SC, Vrana KE (1996) Intricate regulation of tyrosine hydroxylase activity and gene expression. J Neurochem 67:443–462
Dunkley PR, Bobrovskaya L, Graham ME et al (2004) Tyrosine hydroxylase phosphorylation: regulation and consequences. J Neurochem 91:1025–1043. doi:10.1111/j.1471-4159.2004.02797.x
Gordon SL, Quinsey NS, Dunkley PR et al (2008) Tyrosine hydroxylase activity is regulated by two distinct dopamine-binding sites. J Neurochem 106:1614–1623
Andersson KK, Vassort C, Brennan BA et al (1992) Purification and characterization of the blue-green rat phaeochromocytoma (PC12) tyrosine hydroxylase with a dopamine-Fe(III) complex. Reversal of the endogenous feedback inhibition by phosphorylation of serine-40. Biochem J 284(Pt 3):687–695
Daubner SC, Lauriano C, Haycock JW et al (1992) Site-directed mutagenesis of serine 40 of rat tyrosine hydroxylase. Effects of dopamine and cAMP-dependent phosphorylation on enzyme activity. J Biol Chem 267:12639–12646
Ramsey AJ, Fitzpatrick PF (1998) Effects of phosphorylation of serine 40 of tyrosine hydroxylase on binding of catecholamines: evidence for a novel regulatory mechanism. Biochemistry 37:8980–8986. doi:10.1021/bi980582l
Mosharov EV, Staal RG, Bove J et al (2006) Alpha-synuclein overexpression increases cytosolic catecholamine concentration. J Neurosci 26:9304–9311. doi:10.1523/JNEUROSCI.0519-06.2006
Cammarota M, Bevilaqua LR, Rostas JA et al (2003) Histamine activates tyrosine hydroxylase in bovine adrenal chromaffin cells through a pathway that involves ERK1/2 but not p38 or JNK. J Neurochem 84:453–458. doi:10.1046/j.1471-4159.2003.01517.x
Lehmann IT, Bobrovskaya L, Gordon SL et al (2006) Differential regulation of the human tyrosine hydroxylase isoforms via hierarchical phosphorylation. J Biol Chem 281:17644–17651. doi:10.1074/jbc.M512194200
Bevilaqua LR, Graham ME, Dunkley PR et al (2001) Phosphorylation of Ser(19) alters the conformation of tyrosine hydroxylase to increase the rate of phosphorylation of Ser(40). J Biol Chem 276:40411–40416. doi:10.1074/jbc.M105280200
Howlett GJ, Yeh E, Schachman HK (1978) Protein-ligand binding studies with a table-top, air-driven high-speed centrifuge. Arch Biochem Biophys 190:808–819. doi:10.1016/0003-9861(78)90341-7
Reinhard JF Jr, Smith GK, Nichol CA (1986) A rapid and sensitive assay for tyrosine-3-monooxygenase based upon the release of 3H2O and adsorption of [3H]-tyrosine by charcoal. Life Sci 39:2185–2189. doi:10.1016/0024-3205(86)90395-4
Bobrovskaya L, Cheah TB, Bunn SJ et al (1998) Tyrosine hydroxylase in bovine adrenal chromaffin cells: angiotensin II-stimulated activity and phosphorylation of Ser19, Ser31, and Ser40. J Neurochem 70:2565–2573
Jarvie PE, Dunkley PR (1995) Characterization of calcium/calmodulin-stimulated protein kinase II. Methods Mol Biol 41:239–259
Bobrovskaya L, Dunkley PR, Dickson PW (2004) Phosphorylation of Ser19 increases both Ser40 phosphorylation and enzyme activity of tyrosine hydroxylase in intact cells. J Neurochem 90:857–864. doi:10.1111/j.1471-4159.2004.02550.x
Sura GR, Daubner SC, Fitzpatrick PF (2004) Effects of phosphorylation by protein kinase A on binding of catecholamines to the human tyrosine hydroxylase isoforms. J Neurochem 90:970–978. doi:10.1111/j.1471-4159.2004.02566.x
Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann N Y Acad Sci 51:660–672. doi:10.1111/j.1749-6632.1949.tb27297.x
Mosharov EV, Gong LW, Khanna B et al (2003) Intracellular patch electrochemistry: regulation of cytosolic catecholamines in chromaffin cells. J Neurosci 23:5835–5845
Haycock JW (1993) Multiple signaling pathways in bovine chromaffin cells regulate tyrosine hydroxylase phosphorylation at Ser19, Ser31, and Ser40. Neurochem Res 18:15–26. doi:10.1007/BF00966919
Haycock JW (1990) Phosphorylation of tyrosine hydroxylase in situ at serine 8, 19, 31, and 40. J Biol Chem 265:11682–11691
Walkinshaw G, Waters CM (1995) Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson’s disease. J Clin Invest 95:2458–2464. doi:10.1172/JCI117946
Koshimura K, Tanaka J, Murakami Y et al (2000) Effects of dopamine and L-DOPA on survival of PC12 cells. J Neurosci Res 62:112–119. doi:10.1002/1097-4547(20001001)62:1<112::AID-JNR12>3.0.CO;2-6
Basma AN, Morris EJ, Nicklas WJ et al (1995) L-dopa cytotoxicity to PC12 cells in culture is via its autoxidation. J Neurochem 64:825–832
Zhang J, Kravtsov V, Amarnath V et al (2000) Enhancement of dopaminergic neurotoxicity by the mercapturate of dopamine: relevance to Parkinson’s disease. J Neurochem 74:970–978. doi:10.1046/j.1471-4159.2000.0740970.x
Ribeiro P, Wang Y, Citron BA et al (1993) Deletion mutagenesis of rat PC12 tyrosine hydroxylase regulatory and catalytic domains. J Mol Neurosci 4:125–139. doi:10.1007/BF02782125
Ota A, Nakashima A, Mori K et al (1997) Effects of dopamine on N-terminus-deleted human tyrosine hydroxylase type 1 expressed in Escherichia coli. Neurosci Lett 229:57–60. doi:10.1016/S0304-3940(97)00418-7
Nakashima A, Mori K, Suzuki T et al (1999) Dopamine inhibition of human tyrosine hydroxylase type 1 is controlled by the specific portion in the N-terminus of the enzyme. J Neurochem 72:2145–2153. doi:10.1046/j.1471-4159.1999.0722145.x
Stokes AH, Hastings TG, Vrana KE (1999) Cytotoxic and genotoxic potential of dopamine. J Neurosci Res 55:659–665. doi:10.1002/(SICI)1097-4547(19990315)55:6<659::AID-JNR1>3.0.CO;2-C
Youdim MB, Bakhle YS (2006) Monoamine oxidase: isoforms and inhibitors in Parkinson’s disease and depressive illness. Br J Pharmacol 147(Suppl 1):S287–S296. doi:10.1038/sj.bjp.0706464
Jenner P (2003) Oxidative stress in Parkinson’s disease. Ann Neurol 53(Suppl 3):S26–S36. doi:10.1002/ana.10483 discussion S36–28
Acknowledgments
This work was supported by a grant from the National Health and Medical Research Council (No. 455547).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gordon, S.L., Webb, J.K., Shehadeh, J. et al. The Low Affinity Dopamine Binding Site on Tyrosine Hydroxylase: The Role of the N-Terminus and In Situ Regulation of Enzyme Activity. Neurochem Res 34, 1830–1837 (2009). https://doi.org/10.1007/s11064-009-9989-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-009-9989-5